Investment methodology

How we find stocks worth researching.

We focus our research where the market may be wrong. Our proprietary research framework identifies companies where fundamentals, valuation, or structural change suggest a meaningful disconnect between intrinsic business value and prevailing market expectations. These dislocations form the starting point for deeper analysis.

The investment question

Price is an opinion. Value demands research.

We do not select stocks solely because of market narratives, short-term price movements, popularity, or momentum. Every company must earn its place through fundamental research, valuation, risk analysis, and a clearly defined investment thesis.

We call this framework the Eaglewing Research System (EWRS). It connects the stages of our methodology around one objective: understanding what the market appears to believe, where those expectations may be incomplete, and how the potential reward compares with the risks. Explore how EWRS operates →

01 — Discover

Two paths into our research pipeline.

We continuously search public markets for a meaningful divergence between fundamentals, market expectations, and valuation. Ideas primarily originate through one of two permanent research categories.

01 / FDResearch category

Fundamental Dislocations

High-quality or fundamentally attractive businesses where market pricing may have become disconnected from underlying economic reality.

We look for established companies facing share-price weakness, operational pressure, changing sentiment, industry disruption, or macroeconomic strain while retaining potentially attractive underlying economics.

Central question

Has the stock declined because the business is permanently impaired, or because the market may be underestimating its ability to recover?

What we examine
  • Competitive position
  • Revenue durability
  • Pricing power
  • Margins and free cash flow
  • Balance-sheet strength
  • Management execution
  • Capital allocation
  • Cause of the decline
  • Industry conditions
  • Investor expectations
  • Valuation compression
  • Recovery catalysts
  • Long-term earnings power
02 / DTResearch category

Disruptive Technologies

Companies developing technologies with the potential to reshape industries, create new markets, or materially change existing economic structures.

We research businesses at the frontier of technological change where innovation could alter cost structures, competitive dynamics, productivity, business models, consumer behavior, or create entirely new categories of activity.

Central question

If the technology succeeds, could this company become substantially more important and valuable than the market currently expects?

What we examine
  • Technological differentiation
  • Intellectual property
  • Data and infrastructure
  • Engineering advantage
  • Addressable market
  • Commercialization potential
  • Adoption and competition
  • Management and technical talent
  • Execution milestones
  • Regulatory milestones
  • Financial runway
  • Capital and dilution risk
  • Unit economics
  • Path to profitability
  • Strategic partnerships
02

Research

Understand how the business creates economic value.

01

Business

Products, customers, revenue model, competitive advantages, market position, growth opportunity, and underlying economics.

02

Financials

Revenue growth, margins, profitability, free cash flow, capital expenditure, debt, liquidity, dilution, and financing requirements.

03

Industry

Competitors, industry structure, market growth, regulation, technological change, and structural industry forces.

04

Management

Strategy, incentives, execution, track record, capital allocation, acquisitions, financing decisions, and shareholder alignment.

05

Expectations

The assumptions investors already appear to have priced into the stock and the evidence required for those expectations to change.

A great company is not automatically a great investment. Price and expectations matter.
03

Value

Separate the quality of the business from the price of the stock.

We adapt the valuation framework to the economics, maturity, capital structure, and uncertainty of each company. We do not force every business into one model.

  • Discounted cash-flow analysis
  • Earnings multiples
  • Free-cash-flow multiples
  • Enterprise-value frameworks
  • Comparable-company analysis
  • Historical valuation ranges
  • Unit-economic analysis
  • Sum-of-the-parts valuation
  • Probability-weighted outcomes
01

Bear case

What could the company be worth if major assumptions fail or conditions deteriorate?

02

Base case

What could the company be worth if the business develops broadly according to our central expectations?

03

Bull case

What could the company be worth if execution, adoption, or industry conditions materially exceed expectations?

Valuation objective

We are not trying to predict an exact future share price. We are testing whether the potential reward is sufficiently attractive relative to the risks.

04

Challenge

Every investment thesis needs a reason it could be wrong.

01

What is the strongest bear case?

02

What could permanently impair the business?

03

Which assumptions drive most of the valuation?

04

What might the market understand that we are missing?

05

What evidence would contradict the thesis?

06

What events would cause us to reconsider the idea?

07

What is the realistic downside if the thesis is wrong?

08

Is the apparent opportunity compensation for hidden risk?

Strong research should explain both why an investment could work and why it could fail.
05

Select

Conviction must be earned.

01

Monitor

The company is interesting, but there is not yet sufficient evidence to justify deeper conviction.

02

Watchlist

The opportunity appears credible and the key research questions have been identified.

03

Research Candidate

The company has entered deeper fundamental, valuation, catalyst, and risk analysis.

04

Eaglewing Pick

Our research supports a sufficiently compelling risk-reward profile for formal publication as a selected equity idea.

05

Rejected

The business quality, valuation, financial position, evidence, execution risk, or overall risk-reward does not satisfy our standards.

Not every company we research becomes an Eaglewing Pick.

Selectivity is part of the methodology. We do not manufacture recommendations simply to generate content.

06

Publish

Every Eaglewing Pick follows a consistent research framework.

01

The Thesis

Why we believe the opportunity exists.

02

Valuation

What expectations appear embedded in the share price and where potential mispricing may exist.

03

Catalysts

The developments that could change the market's perception of the company.

04

Risks

The major factors that could weaken the investment case.

05

Failure Conditions

The evidence or developments that would invalidate the original thesis.

06

Time Horizon

Whether the opportunity depends on near-term developments, medium-term execution, or a long-term structural thesis.

07

Research Classification

Whether the idea originated through a Fundamental Dislocation or a Disruptive Technology.

Publication standard

Structured for clarity, comparison, and future updates.

As the platform develops, published stock pages are designed to support a consistent set of research fields without requiring every company to fit the same analytical model.

  • Company and ticker
  • Sector and industry
  • Research category
  • Date initiated
  • Current research status
  • Investment thesis
  • Key valuation assumptions
  • Bear, base, and bull cases
  • Catalysts
  • Risks
  • Failure conditions
  • Time horizon
  • Key financial metrics
  • Latest research update
07

Track

Publishing a stock pick is the beginning of the research process, not the end.

We continue to monitor the business, its industry, valuation, and the thesis-specific evidence that supported publication.

  • Earnings results
  • Revenue and profitability
  • Cash generation
  • Management guidance
  • Competitive developments
  • Industry conditions
  • Technological progress
  • Commercialization milestones
  • Regulatory developments
  • Strategic partnerships
  • Capital allocation
  • Financing and dilution
  • Valuation changes
  • Thesis-specific catalysts
  • Thesis-specific risks
A stock does not remain attractive simply because we previously liked it. New evidence may strengthen, weaken, or invalidate the original thesis.
08

Review

We evaluate the research after the outcome.

We review published ideas against the original thesis and the evidence that followed. We do not let performance alone dominate the methodology; we use each review to improve the quality and repeatability of future research.

  1. 01Original investment thesis
  2. 02Subsequent company developments
  3. 03Stock and benchmark performance
  4. 04Catalysts that occurred or failed to occur
  5. 05Assumptions that proved correct or incorrect
  6. 06Analytical errors and changes in risk
  7. 07Lessons for future research

Our research philosophy

Evidence before conviction.

Good equity research requires more than identifying great companies. It requires understanding businesses, identifying market expectations, valuing uncertain futures, challenging attractive narratives, recognizing risk, and changing our minds when the evidence changes.